IMW 2019 | Promising outlook for MM patients

Gösta Gahrton

Gösta Gahrton, MD, of Karolinska University Hospital, Stockholm, Sweden, talks about the outlook for multiple myeloma patients. Dr Gahrton suggests that new drugs should be combined with approaches such as allogeneic transplants, CAR-T cells and CAR-NK cells. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter